MS Butler - Natural product reports, 2005 - rsc.org Natural product and natural product-derived compounds that are being evaluated in clinical trials
or in registration (current 31 December 2004) have been reviewed. Natural product derived drugs
launched in the United States of America, Europe and Japan since 1998 and new natural ... Cited by 144 - Related articles - BL Direct - All 14 versions
- ►physiology.org IG Obrosova, VR Drel, CL Oltman, N … - American Journal of …, 2007 - Am Physiological Soc Evidence for important roles of the highly reactive oxidant peroxynitrite in diabetic complications
is emerging. We evaluated the role of peroxynitrite in early peripheral neuropathy and vascular
dysfunction in STZ-diabetic rats. In the first dose-finding study, control and STZ-diabetic ... Cited by 17 - Related articles - BL Direct - All 5 versions
CL Oltman, EP Davidson, LJ Coppey, TL Kleinschmidt, … - Obesity, 2008 - nature.com Enalapril treatment decreased serum angiotensin-converting enzyme (ACE) activity and both
drugs reduced serum cholesterol levels. In obese Zucker rats at 32 weeks of age superoxide
levels were elevated in the aortas and epineurial arterioles, which were reduced by ... Cited by 6 - Related articles - All 3 versions
MA Yorek - Current Drug Targets, 2008 - ingentaconnect.com Abstract: Diabetic neuropathy is a debilitating disorder that occurs in more than 50 percent of
patients with diabetes. Evidence suggests that there are at least five major pathways involved
in the development of diabetic neuropathy: meta- bolic, vascular, immunologic, ... Cited by 4 - Related articles - BL Direct - All 3 versions
CL Oltman, EP Davidson, LJ Coppey, TL … - Diabetes, obesity & …, 2009 - pubmedcentral.nih.gov Vasopeptidase inhibitors are drugs that inhibit angiotensin-converting enzyme and neutral endopeptidase
(NEP). The latter is a protease that degrades vasoactive peptides and is increased in
diabetes. We have previously shown that treating streptozotocin-induced diabetic rats, an ... Cited by 3 - Related articles - All 5 versions
I VARENIUK, PAL PACHER, IA PAVLOV, … - … journal of molecular …, 2009 - pubmedcentral.nih.gov Evidence for the important role of the potent oxidant peroxynitrite in peripheral diabetic neuropathy
and neuropathic pain is emerging. This study evaluated the contribution of neuronal nitric oxide
synthase (nNOS) to diabetes-induced nitrosative stress in peripheral nerve and dorsal ... Cited by 1 - Related articles - All 4 versions
EP Davidson, LJ Coppey, TL Kleinschmidt, CL … - Experimental Diabetes …, 2009 - hindawi.com Page 1. Hindawi Publishing Corporation Experimental Diabetes Research Volume 2009,
Article ID 912327, 8 pages doi:10.1155/2009/912327 Research Article Vascular and
Neural Dysfunctions in Obese Zucker Rats: Effect of AVE7688 ... Cited by 1 - Related articles - View as HTML - All 11 versions
K Tarhzaoui, P Valensi, G Leger, F Cohen- … - Diabetes Res Clin …, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 1 - Related articles - All 3 versions
P Eric… - Experimental Diabetes Research, 2009 - hindawi.com The purpose of this study was to determine whether AVE7688 a drug that inhibits both angiotensin
converting enzyme and neutral endopeptidase activity protects vascular and nerve functions
in an animal model of metabolic syndrome. Obese Zucker rats at 20 weeks of age were ... Related articles - Cached - All 2 versions
[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last …
